As of May 31, 2025, Thomson Medical Group Ltd (A50.SI) reports a ROE (Return on Equity) of 3.08%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Thomson Medical Group Ltd's ROE (Return on Equity)
Over recent years, Thomson Medical Group Ltd's ROE (Return on Equity) has shown a stable trend. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2024-06-30 | 3.08% |
| 2023-06-30 | 7.32% |
| 2022-06-30 | 10.11% |
| 2021-06-30 | 2.91% |
| 2020-06-30 | -20.76% |
This slight downward trend highlights how Thomson Medical Group Ltd manages its efficiency in generating profits from shareholders' equity over time.
Comparing Thomson Medical Group Ltd's ROE (Return on Equity) to Peers
To better understand Thomson Medical Group Ltd's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Thomson Medical Group Ltd (A50.SI) | 3.08% |
| Bumrungrad Hospital PCL (BH.BK) | 28.28% |
| Narayana Hrudayalaya Ltd (NH.NS) | 27.37% |
| Amvis Holdings Inc (7071.T) | 22.40% |
| Singapore O&G Ltd (1D8.SI) | 19.57% |
| National Medical Care Company JSC (4005.SR) | 17.74% |
Compared to its competitors, Thomson Medical Group Ltd's ROE (Return on Equity) is about average compared to peers, reflecting standard industry returns on equity investment.